Plan B One-Step Boosts Teva's Women's Health Business
This article was originally published in The Tan Sheet
Executive Summary
After a rocky launch, sales of Teva Pharmaceuticals' Plan B One-Step (levonorgestrel 1.5 mg) grew 55% in the firm's fiscal 2010 third quarter, Teva said Nov. 2.
You may also be interested in...
P&G/Teva Joint Venture Lays Foundation For Switches, Product Launches
Procter & Gamble and Teva Pharmaceutical Industries combine their consumer businesses in a joint venture that creates a leading platform for Rx-to-OTC switches and new consumer health products.
P&G/Teva Joint Venture Lays Foundation For Switches, Product Launches
Procter & Gamble and Teva Pharmaceutical Industries combine their consumer businesses in a joint venture that creates a leading platform for Rx-to-OTC switches and new consumer health products.
P&G/Teva Joint Venture Lays Foundation For Switches, Product Launches
Procter & Gamble and Teva Pharmaceutical Industries combine their consumer businesses in a joint venture that creates a leading platform for Rx-to-OTC switches and new consumer health products.